Amgen Launches Rituxan Rival In US

As Company Reflects On Future Of Biosimilars In US

 
• By Akriti Seth
  
biosimilar_syringe
Amgen launches its third oncology biosimilar in the US market • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin